“This is the first time that we are unifying these three important biomarkers, so that patients can get the result as quickly as possible and get treated as soon as possible,” said Ongsue-Lee. Previously, patients had to undergo separate tests for each of these three biomarkers. “Starting April 1, we will be distributing the forms to our doctors and partners and they can just submit it to any HP [Hi-Precision] branch near their locations and we’ll do the test for them.

After launching its first two pilots in Spain and Hungary last year, FT3 is embarking on an important journey with the launch of the Philippines pilot program for cancer care. Dedicated to better patient experiences, this initiative works to overcome obstacles that prevent people from accessing personalized healthcare.

Continuing coverage on Hit the Mark #trident now in #Businessmirror